Original language | English |
---|---|
Article number | 827 |
Number of pages | 3 |
Journal | Frontiers in Pharmacology |
Volume | 11 |
DOIs |
|
Publication status | Published - 2-Jun-2020 |
Commentary: "Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease" by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519
Harma Alma*, Corina de Jong, Janwillem Kocks, Thys van der Molen
*Corresponding author for this work
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
48
Downloads
(Pure)